What does high c-peptide mean?

High C-peptide levels typically indicate your pancreas is producing excess insulin, often due to insulin resistance, prediabetes, or type 2 diabetes. This biomarker helps distinguish between different types of diabetes and can signal metabolic dysfunction before blood sugar becomes elevated.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding C-Peptide and Its Role in Your Body

C-peptide is a protein that your pancreas releases alongside insulin whenever you produce this crucial blood sugar-regulating hormone. Think of C-peptide as insulin's shadow—for every molecule of insulin your body makes, it produces an equal amount of C-peptide. This one-to-one relationship makes C-peptide an excellent biomarker for understanding how much insulin your pancreas is producing.

Unlike insulin, which gets quickly used up by your cells, C-peptide stays in your bloodstream longer and remains more stable. This stability makes it a more reliable indicator of insulin production than measuring insulin directly. When your C-peptide levels are high, it typically means your pancreas is working overtime to produce insulin—often a sign that your body's cells aren't responding properly to insulin's signals.

Why C-Peptide Testing Matters

C-peptide testing serves several important purposes in understanding your metabolic health. First, it helps distinguish between type 1 and type 2 diabetes—people with type 1 diabetes have low or absent C-peptide levels because their pancreas produces little to no insulin, while those with type 2 diabetes often have normal or high levels. Second, it can detect insulin resistance before your blood sugar levels become problematic, giving you an early warning sign to take preventive action.

C-Peptide Level Interpretation Guide

C-Peptide Level (ng/mL)CategoryClinical SignificanceTypical Action
<0.5<0.5LowPossible Type 1 diabetes or late-stage Type 2Further testing, possible insulin therapy
0.5-2.00.5-2.0NormalHealthy insulin productionMaintain healthy lifestyle
2.1-3.02.1-3.0ElevatedEarly insulin resistanceLifestyle modifications, monitor regularly
>3.0>3.0HighSignificant insulin resistance or insulinomaComprehensive evaluation, aggressive intervention

C-peptide levels should be interpreted alongside other metabolic markers and clinical symptoms for accurate assessment.

Normal vs. High C-Peptide Levels

Normal C-peptide levels typically range from 0.5 to 2.0 nanograms per milliliter (ng/mL) when fasting, though this can vary slightly between laboratories. After eating, these levels naturally rise as your pancreas releases insulin to help process the glucose from your meal. Understanding where your levels fall within or outside this range provides valuable insight into your metabolic health.

High C-peptide levels, generally considered anything above 2.0 ng/mL when fasting, suggest your pancreas is producing excessive amounts of insulin. This overproduction usually occurs because your cells have become resistant to insulin's effects, forcing your pancreas to compensate by making more. Think of it like having to shout louder and louder to be heard in a noisy room—your pancreas is essentially "shouting" insulin at cells that have stopped listening effectively.

Factors That Influence C-Peptide Levels

Several factors can affect your C-peptide levels beyond insulin resistance. Recent meals, especially those high in carbohydrates, will naturally elevate C-peptide as your body responds to rising blood sugar. Certain medications, including sulfonylureas used to treat diabetes, can stimulate insulin production and raise C-peptide levels. Kidney function also plays a role, as the kidneys help clear C-peptide from your blood—impaired kidney function can lead to falsely elevated readings.

Common Causes of High C-Peptide

Insulin Resistance and Prediabetes

The most common cause of elevated C-peptide is insulin resistance, a condition where your cells don't respond properly to insulin's signal to absorb glucose from the bloodstream. As cells become increasingly resistant, your pancreas compensates by producing more insulin (and therefore more C-peptide) to maintain normal blood sugar levels. This compensation can work for years, keeping your blood sugar in check while C-peptide levels climb higher and higher.

Prediabetes represents the stage where this compensation begins to fail. Your pancreas is still producing plenty of insulin, but it's no longer enough to keep blood sugar completely normal. During this phase, C-peptide levels often remain elevated or even increase further as your pancreas struggles to keep up with demand. Regular monitoring of C-peptide alongside other metabolic markers can help identify this critical window for intervention.

Type 2 Diabetes

In early type 2 diabetes, C-peptide levels typically remain high as the pancreas continues its efforts to overcome insulin resistance. However, as the disease progresses, the insulin-producing beta cells in the pancreas can become exhausted or damaged, leading to a gradual decline in both insulin and C-peptide production. This progression explains why some people with long-standing type 2 diabetes may eventually need insulin therapy—their pancreas can no longer keep up with demand.

Other Medical Conditions

Several other conditions can cause elevated C-peptide levels:

  • Insulinomas: Rare tumors of the pancreas that produce excess insulin
  • Cushing's syndrome: Excess cortisol production that can impair insulin sensitivity
  • Polycystic ovary syndrome (PCOS): Often associated with insulin resistance
  • Metabolic syndrome: A cluster of conditions including high blood pressure, excess body fat around the waist, and abnormal cholesterol levels
  • Kidney disease: Reduced clearance of C-peptide from the blood

Symptoms Associated with High C-Peptide

High C-peptide itself doesn't cause symptoms directly. Instead, the symptoms you might experience are related to the underlying insulin resistance or the blood sugar fluctuations that often accompany it. Many people with elevated C-peptide levels feel completely normal, which is why testing is so valuable for early detection of metabolic problems.

When symptoms do occur, they often include:

  • Fatigue, especially after meals
  • Difficulty losing weight despite diet and exercise efforts
  • Increased hunger and cravings, particularly for carbohydrates
  • Dark, velvety patches of skin (acanthosis nigricans) in body folds
  • Frequent urination and increased thirst (when blood sugar becomes elevated)
  • Blurred vision during blood sugar fluctuations
  • Slow wound healing
  • Recurrent infections

Health Implications of Elevated C-Peptide

Cardiovascular Risks

Research has shown that high C-peptide levels are associated with increased cardiovascular risk, independent of other factors. The chronic hyperinsulinemia (excess insulin) that accompanies elevated C-peptide can damage blood vessels, promote atherosclerosis, and increase the risk of heart attack and stroke. Some studies suggest that C-peptide itself may have direct effects on blood vessel function, though this remains an area of active research.

Metabolic Consequences

Elevated C-peptide levels signal that your metabolism is under stress. This metabolic dysfunction extends beyond just blood sugar control. High insulin levels can promote fat storage, particularly around the midsection, making weight loss more difficult. They can also affect hormone balance, contributing to conditions like PCOS in women and potentially affecting testosterone levels in men. The metabolic strain can also impact liver function, potentially leading to non-alcoholic fatty liver disease.

Testing and Monitoring C-Peptide Levels

C-peptide testing is typically done through a simple blood draw, ideally after fasting for 8-12 hours to get a baseline reading. Some healthcare providers may also order a stimulated C-peptide test, where you consume a standardized amount of glucose and have your levels checked at specific intervals afterward. This can provide additional information about how your pancreas responds to a glucose challenge.

For comprehensive metabolic health monitoring, C-peptide should be evaluated alongside other key biomarkers including fasting glucose, hemoglobin A1c, insulin levels, and lipid panels. This broader picture helps identify patterns of insulin resistance and metabolic dysfunction that might not be apparent from a single test. Regular monitoring every 3-6 months can help track your progress as you implement lifestyle changes or medical treatments.

When to Get Tested

Consider C-peptide testing if you have:

  • A family history of type 2 diabetes
  • Signs of insulin resistance or metabolic syndrome
  • Difficulty losing weight despite appropriate diet and exercise
  • PCOS or unexplained hormonal imbalances
  • A new diagnosis of diabetes (to help determine type)
  • Unexplained episodes of low blood sugar

Strategies to Lower High C-Peptide Levels

Dietary Modifications

The most effective dietary approach for lowering C-peptide levels focuses on improving insulin sensitivity. This typically involves reducing refined carbohydrates and added sugars while emphasizing whole foods, lean proteins, healthy fats, and fiber-rich vegetables. Many people find success with lower-carbohydrate approaches, though the optimal macronutrient balance varies by individual. Time-restricted eating or intermittent fasting can also help improve insulin sensitivity by giving your pancreas regular breaks from producing insulin.

Key dietary strategies include:

  • Choosing complex carbohydrates over simple sugars
  • Pairing carbohydrates with protein and healthy fats
  • Eating vegetables before starches to blunt glucose response
  • Avoiding sugary beverages and processed foods
  • Incorporating foods rich in chromium, magnesium, and omega-3 fatty acids

Exercise and Physical Activity

Regular physical activity is one of the most powerful tools for improving insulin sensitivity and lowering C-peptide levels. Both aerobic exercise and resistance training offer benefits, with the combination being particularly effective. Exercise helps muscles take up glucose more efficiently, reducing the demand on your pancreas to produce insulin. Even a single bout of exercise can improve insulin sensitivity for up to 48 hours.

Aim for at least 150 minutes of moderate-intensity aerobic activity per week, plus two or more days of strength training. High-intensity interval training (HIIT) has shown particular promise for improving metabolic health in less time. The key is consistency—regular movement throughout the day, even just walking after meals, can significantly impact your insulin sensitivity and C-peptide levels.

Weight Management and Lifestyle Factors

If you're carrying excess weight, particularly around your midsection, losing even 5-10% of your body weight can significantly improve insulin sensitivity and lower C-peptide levels. However, the relationship between weight and insulin resistance is complex—focus on sustainable lifestyle changes rather than rapid weight loss, which can actually worsen metabolic health.

Other important lifestyle factors include:

  • Getting 7-9 hours of quality sleep nightly
  • Managing stress through meditation, yoga, or other relaxation techniques
  • Limiting alcohol consumption
  • Quitting smoking if applicable
  • Staying well-hydrated throughout the day

Taking Action for Better Metabolic Health

High C-peptide levels serve as an early warning sign that your metabolic health needs attention. While elevated levels indicate your pancreas is working hard to maintain blood sugar control, this compensation can't last forever. The good news is that insulin resistance is largely reversible through lifestyle modifications, and catching it early—when C-peptide levels are high but blood sugar is still normal—offers the best opportunity for prevention.

Remember that improving metabolic health is a journey, not a destination. Small, consistent changes in diet, exercise, sleep, and stress management can lead to significant improvements in insulin sensitivity and C-peptide levels over time. Regular monitoring helps you track progress and adjust your approach as needed. By taking action now, you can protect your long-term health and reduce your risk of developing type 2 diabetes and related complications.

References

  1. Jones, A. G., & Hattersley, A. T. (2013). The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabetic Medicine, 30(7), 803-817.[Link][PubMed][DOI]
  2. Patel, N., Taveira, T. H., Choudhary, G., Whitlatch, H., & Wu, W. C. (2012). Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults. Journal of the American Heart Association, 1(6), e003152.[PubMed][DOI]
  3. Li, Y., Li, Y., Meng, L., & Zheng, L. (2015). Association between serum C-peptide as a risk factor for cardiovascular disease and high-density lipoprotein cholesterol levels in nondiabetic individuals. PLoS One, 10(1), e112281.[PubMed][DOI]
  4. Abdullah, A., Hasan, H., & Raigangar, V. (2021). C-Peptide versus insulin: relationships with risk biomarkers of cardiovascular disease in metabolic syndrome in young Arab females. International Journal of Endocrinology, 2021, 5513257.[PubMed][DOI]
  5. Wahren, J., Kallas, Å., & Sima, A. A. (2012). The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes, 61(4), 761-772.[PubMed][DOI]
  6. Leighton, E., Sainsbury, C. A., & Jones, G. C. (2017). A practical review of C-peptide testing in diabetes. Diabetes Therapy, 8(3), 475-487.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my C-peptide at home?

You can test your C-peptide at home with SiPhox Health's Core Health Program or Heart & Metabolic Program. Both programs include C-peptide testing along with other essential metabolic biomarkers, providing lab-quality results from the comfort of your home.

What is the difference between C-peptide and insulin tests?

While both reflect insulin production, C-peptide is more stable and stays in your blood longer than insulin, making it a more reliable marker. C-peptide also isn't affected by injected insulin, so it can show your natural insulin production even if you're taking insulin medication.

Can high C-peptide levels be reversed?

Yes, high C-peptide levels caused by insulin resistance can often be reversed through lifestyle changes including dietary modifications, regular exercise, weight loss, stress management, and adequate sleep. The key is addressing the underlying insulin resistance.

What C-peptide level indicates diabetes?

C-peptide levels alone don't diagnose diabetes. Type 1 diabetes typically shows low C-peptide (<0.5 ng/mL), while type 2 diabetes often shows normal or high levels (>2.0 ng/mL). Diagnosis requires additional tests like fasting glucose and HbA1c.

Should I fast before a C-peptide test?

Yes, fasting for 8-12 hours before a C-peptide test provides the most accurate baseline reading. This eliminates the influence of recent meals on your results and allows for better comparison with reference ranges.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details